Evaluate for indications of opioid withdrawal. If a CYP3A4 inducer is discontinued, take into consideration OXYCONTIN dosage reduction and evaluate patients at frequent intervals for indications of respiratory depression and sedation. Soon after halting a CYP3A4 inducer, as the effects of the inducer decrease, the oxycodone plasma concentration will https://frankv652dar7.slypage.com/profile